Denis Chem Lab logo

Denis Chem Lab

DENISCHEMLABLTD NSE

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
Market Cap
₹99.82 Cr
Volatility
Moderate
P/E Ratio
12.5
EBITDA
₹19.60 Cr
Return on Equity
9.18%
Debt to Equity
0.04
Book Value
₹65.99
EPS
₹8.04
52W High
₹100.5
52W Low
₹56.1

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

4
  • Company is almost debt free.
  • Stock is trading at 1.08 times its book value
  • Stock is providing a good dividend yield of 3.50%.
  • Company has been maintaining a healthy dividend payout of 32.7%

Weaknesses

3
  • The company has delivered a poor sales growth of 10.8% over past five years.
  • Promoter holding is low: 39.0%
  • Company has a low return on equity of 11.2% over last 3 years.

Growth Rate

Revenue Growth
4.5% higher than 3Y
Net Income Growth
3.7% higher than 3Y
Cash Flow Change
-65.84% higher than 3Y
ROE
-3.27% lower than 3Y
ROCE
1.26% higher than 3Y
EBITDA Margin (Avg.)
1.33% higher than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
42.48
45.43
40.06
39.85
41.26
47.82
42.84
41.38
43.28
46.17
45.52
46.75
44
Expenses
37.45
40.29
34.07
34.77
36.91
41.94
39.01
39.32
38.46
41.91
39.49
44.21
40.17
Operating Profit
5.03
5.14
5.99
5.08
4.35
5.88
3.83
2.06
4.82
4.26
6.03
2.54
3.83
OPM %
11.84%
11.31%
14.95%
12.75%
10.54%
12.3%
8.94%
4.98%
11.14%
9.23%
13.25%
5.43%
8.7%
Other Income
0.01
0.52
0.26
0.59
0.32
0.58
0.3
1.17
0.3
0.65
0.44
0.54
0.45
Interest
0.09
0.09
0.13
0.23
0.12
0.09
0.07
0.23
0.19
0.23
0.22
0.2
0.11
Depreciation
1.59
1.76
1.84
1.75
1.63
1.66
1.84
1.73
1.61
1.65
1.83
1.74
1.53
PBT
3.36
3.81
4.28
3.69
2.92
4.71
2.22
1.27
3.32
3.03
4.42
1.14
2.64
Tax %
20.24%
33.07%
25.23%
26.02%
28.77%
25.05%
20.72%
44.09%
25.3%
27.06%
24.66%
64.91%
22.73%
Net Profit
2.68
2.54
3.2
2.73
2.08
3.53
1.76
0.71
2.48
2.21
3.32
0.4
2.05
EPS in Rs
1.93
1.83
2.31
1.97
1.5
2.54
1.27
0.51
1.79
1.59
2.39
0.29
1.48
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
75
98
112
107
123
135
109
136
161
167
173
181
182
Expenses
66
89
98
95
110
120
99
122
142
146
157
164
166
Operating Profit
9
8
14
12
14
15
10
14
19
21
16
18
17
OPM %
12%
9%
12%
11%
11%
11%
9%
11%
12%
13%
9%
10%
9%
Other Income
0
0
1
1
2
0
0
1
1
1
2
2
2
Interest
5
7
6
5
3
3
2
1
1
1
1
1
1
Depreciation
4
6
7
6
6
7
6
6
8
7
7
7
7
PBT
0
-3
2
2
6
6
3
9
11
15
11
12
11
Tax %
78%
30%
37%
-5%
-7%
26%
27%
30%
28%
26%
27%
29%
Net Profit
0
-4
1
2
6
4
2
6
8
11
8
8
8
EPS in Rs
0.07
-4.16
0.89
1.54
4.58
3.03
1.63
4.51
5.66
8.04
5.82
6.06
5.75
Div. Payout %
0%
0%
0%
0%
22%
0%
46%
33%
35%
31%
26%
41%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
9
9
12
14
14
14
14
14
14
14
14
14
Reserves
8
7
18
36
43
45
48
53
58
66
71
78
Borrowings
48
44
37
25
23
14
9
3
2
1
1
4
Other Liabilities
17
24
27
26
26
25
22
27
25
28
26
29
Total Liabilities
81
85
94
101
106
97
92
96
99
109
112
125
Fixed Assets
42
40
44
40
50
46
41
42
35
38
39
37
CWIP
0
10
1
5
0
0
0
0
2
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
39
35
49
56
55
52
51
55
62
72
73
88
Total Assets
81
85
94
101
106
97
92
96
99
109
112
125
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
14
21
7
11
8
13
8
17
16
18
12
4
Investing
-28
-13
-1
-16
-2
-2
-1
-10
-11
-15
-8
-5
Financing
13
-7
0
1
-5
-14
-6
-7
-4
-4
-4
0
Net Cash Flow
-1
1
5
-4
1
-3
1
0
1
-1
0
0
Free Cash Flow
-14
8
5
2
-2
11
6
12
12
11
4
-1
CFO/OP
154
246
49
92
65
101
85
126
100
104
105
38
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
123
85
104
105
106
94
110
85
71
69
65
78
Inventory Days
40
39
35
52
50
51
60
50
39
43
37
40
Days Payable
81
119
136
150
102
108
103
99
79
90
81
81
Cash Conversion Cycle
81
4
3
8
55
37
67
36
31
22
21
36
Working Capital Days
-19
-57
-13
4
17
32
63
51
41
37
38
50
ROCE %
11%
5%
12%
9%
11%
11%
6%
14%
16%
20%
14%
14%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Denis Chem Lab insights

66 extracted metrics + investor summaries across FY11–FY26.

Log in — free

Shareholding Pattern

FIIs0.01%Promot.38.98%Public29.48%Others31.53%As ofJun 2026

Documents

Frequently Asked Questions about Denis Chem Lab

What does Denis Chem Lab Ltd do?
Incorporated in 1982, Denis Chem Lab Ltd does manufacturing of Pharmaceuticals Transfusion Solution in Bottles[1]
Where is Denis Chem Lab Ltd (537536) listed?
Denis Chem Lab Ltd trades as DENISCHEMLABLTD on the NSE and under code DENISCHEM on the BSE.
Which sector does Denis Chem Lab Ltd belong to?
Denis Chem Lab Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Denis Chem Lab Ltd?
Denis Chem Lab Ltd has a market capitalisation of ₹99.82 Cr, which places it in the Small Cap band.
What is the PE ratio of Denis Chem Lab Ltd?
Denis Chem Lab Ltd trades at a PE ratio of 12.50, on earnings per share of ₹8.04, against a book value of ₹65.99 per share.
What is the 52-week high and low of Denis Chem Lab Ltd?
Over the last 52 weeks Denis Chem Lab Ltd has traded between ₹56.1 and ₹100.5.
Does Denis Chem Lab Ltd pay dividends?
Denis Chem Lab Ltd has a dividend yield of 3.48%.
What is the Return on Equity (ROE) of Denis Chem Lab Ltd?
Denis Chem Lab Ltd reported a return on equity of 9.18%. Its debt-to-equity ratio is 0.04.

Company Information

Incorporated in 1982, Denis Chem Lab Ltd does manufacturing of Pharmaceuticals Transfusion Solution in Bottles[1]

Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/537536.md for Denis Chem Lab Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More